DMARDs, or disease-modifying antirheumatic drugs, may take 6-12 weeks to show effectiveness in treating rheumatoid arthritis, according to Dr. Eric M. Ruderman, a rheumatologist at Northwestern Medicine Rheumatology. DMARDs, which were once a secondary treatment option, are now prescribed at the onset of diagnosis due to their abilities to block inflammation and slow the disease’s progression, potentially leading to remission in the long term. They may also prevent future joint damage. However, as they don’t cure the disease, patients typically continue taking the medication long term.
![](https://healsecurity.com/wp-content/uploads/2024/07/group-ibs-threat-intelligence-and-defence-centre-equip-undergraduates-with-sophisticated.jpg)
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some